Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use CAPRELSA safely and effectively. See full prescribing information for CAPRELSA.CAPRELSA® (vandetanib) tablets, for oral useInitial U.S. Approval: 2011
Medication labelWhy this: Advisory · dailymed-prescription
CAPRELSA is indicated for the treatment of symptomatic or progressive medullary thyroid cancer in patients with unresectable locally advanced or metastatic disease. Use CAPRELSA in patients with indolent, asymptomatic or slowly progressing disease only after careful consideration of the treatment related risks of CAPRELSA.
- generic_name
- vandetanib
- product_names
- Vandetanib
- ndc
- 58468-7820, 58468-7840, 58468-7820-3, 58468-7840-3
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en